Grifols Biologicals LLC

Form 483 issued May 3, 2024 · Los Angeles, California

Inspection
Apr 25 – May 3, 2024
Investigator
Peng Zhou
Observations
2
Pages
4
FEI number
2080769

In short: On May 3, 2024, FDA issued a Form 483 with 2 observations to Grifols Biologicals LLC in Los Angeles, California (FEI 2080769) after an inspection that ran Apr 25 – May 3, 2024. The investigator was Peng Zhou. Most observations concern facilities & equipment and quality system; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Facilities & equipment and quality system account for 2 of 2 observations.

Facilities & equipment1
Quality system1

Most cited: 21 CFR 211.42(c)(10)(iv) (1×) · 211.198(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Aseptic processing areas are deficient regarding the system…

  2. 02

    Procedures describing the handling of written and oral complaints related to drug products are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Grifols Biologicals LLC?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment and quality system. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Grifols Biologicals LLC?

Peng Zhou is named on this Form 483, for the inspection of Apr 25 – May 3, 2024. Each investigator has a profile showing what they cite most.

When was Grifols Biologicals LLC inspected by FDA?

The inspection ran Apr 25 – May 3, 2024, and the Form 483 is dated May 3, 2024.

How do I get the full Form 483 for Grifols Biologicals LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free